BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36440692)

  • 21. Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer.
    Nagashima I; Oka T; Hamada C; Naruse K; Osada T; Muto T
    Am J Gastroenterol; 1999 Mar; 94(3):739-43. PubMed ID: 10086660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth pattern of colorectal liver metastasis as a marker of recurrence risk.
    Eefsen RL; Vermeulen PB; Christensen IJ; Laerum OD; Mogensen MB; Rolff HC; Van den Eynden GG; Høyer-Hansen G; Osterlind K; Vainer B; Illemann M
    Clin Exp Metastasis; 2015 Apr; 32(4):369-81. PubMed ID: 25822899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the Impact of Primary Tumour Location on Survival After Resection of Colorectal Liver Metastases: A Propensity Weighted Retrospective Cohort Study.
    Borakati A; Froghi F; Shetye A; Fusai GK; Davidson BR; Mirnezami R
    World J Surg; 2022 Jul; 46(7):1734-1755. PubMed ID: 35325347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Larger hepatic metastases are more frequent with N0 colorectal tumours and are associated with poor prognosis: implications for surveillance.
    Partelli S; Mukherjee S; Mawire K; Hutchins RR; Abraham AT; Bhattacharya S; Kocher HM
    Int J Surg; 2010; 8(6):453-7. PubMed ID: 20601252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Important CT and histopathological findings for recurrence and overall survival in patients with pancreatic ductal adenocarcinoma who underwent surgery after neoadjuvant FOLFIRINOX.
    Park SJ; Kim JH; Joo I; Lee KB; Han JK
    Eur Radiol; 2021 Jun; 31(6):3616-3626. PubMed ID: 33201279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Role for Primary Tumor Location in Patients With Colorectal Liver Metastases: A Comparison of Right-Sided Colon, Left-Sided Colon, and Rectum.
    Takamizawa Y; Shida D; Horie T; Tsukamoto S; Esaki M; Shimada K; Kondo T; Kanemitsu Y
    Dis Colon Rectum; 2023 Feb; 66(2):233-242. PubMed ID: 35714342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.
    Tsai MS; Su YH; Ho MC; Liang JT; Chen TP; Lai HS; Lee PH
    Ann Surg Oncol; 2007 Feb; 14(2):786-94. PubMed ID: 17103254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer.
    Suthananthan AE; Bhandari M; Platell C
    ANZ J Surg; 2018 May; 88(5):445-449. PubMed ID: 28512795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
    Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
    Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of clinicopathological features and prognosis of 1315 cases in colorectal cancer located at different anatomical subsites.
    Feng Z; Shi X; Zhang Q; Zhang X; Li X; Chen Z; Liu D; Sun B; Zuo Y; Ren S
    Pathol Res Pract; 2019 Oct; 215(10):152560. PubMed ID: 31375274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphatic Invasion is an Independent Adverse Prognostic Factor in Patients with Colorectal Liver Metastasis.
    de Ridder JA; Knijn N; Wiering B; de Wilt JH; Nagtegaal ID
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S638-45. PubMed ID: 25986865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study.
    Kelm M; Schollbach J; Anger F; Wiegering A; Klein I; Germer CT; Schlegel N; Kunzmann V; Löb S
    BMC Cancer; 2021 May; 21(1):490. PubMed ID: 33941104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome.
    Poultsides GA; Bao F; Servais EL; Hernandez-Boussard T; DeMatteo RP; Allen PJ; Fong Y; Kemeny NE; Saltz LB; Klimstra DS; Jarnagin WR; Shia J; D'Angelica MI
    Ann Surg Oncol; 2012 Sep; 19(9):2797-804. PubMed ID: 22476753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resection of synchronous liver metastases from colorectal cancer.
    Fujita S; Akasu T; Moriya Y
    Jpn J Clin Oncol; 2000 Jan; 30(1):7-11. PubMed ID: 10770561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
    Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F
    Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Expanding Metal Stents Do Not Adversely Affect Long-term Outcomes in Acute Malignant Large-Bowel Obstruction: A Retrospective Analysis.
    Browne IL; Mahsin M; Drolet S; Buie WD; Heine JA; MacLean AR
    Dis Colon Rectum; 2022 Feb; 65(2):228-237. PubMed ID: 34990424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
    Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
    Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
    Mizuno T; Cloyd JM; Vicente D; Omichi K; Chun YS; Kopetz SE; Maru D; Conrad C; Tzeng CD; Wei SH; Aloia TA; Vauthey JN
    Eur J Surg Oncol; 2018 May; 44(5):684-692. PubMed ID: 29551247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.